FDA authorizes COVID drug Pemgarda for high-risk patients

A Yale Medicine expert explains the significance of a new pre-exposure prophylaxis (PrEP) medication to protect immunocompromised people against COVID-19.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news